Sunday, December 6, 2020
Home Life Style Health & Fitness India Confident of Covid Vaccine, Trial Stage Marks 'Beginning of the End'

India Confident of Covid Vaccine, Trial Stage Marks ‘Beginning of the End’

Beginning of end as India sounds confident of Covid vaccine

As India races to bring a vaccine for Covid-19 by mid August, the government on Sunday said that it is entering the human trial stage which “marks the beginning of the end”.

COVAXIN by Bharat Biotech and ZyCov-D vaccine by Zydus Cadila are India’s own efforts to bring a vaccine for this pandemic. Along with the two Indian efforts, the world over, 11 out of 140 vaccine candidates have entered the human trial phase.

Follow NewsGram on LinkedIn to know what’s happening around the world.

It also said that six Indian companies are working on a vaccine for COVID-19.

Allaying speculations about India’s ability, the ministry of Science and technology said, “In the past years, India has emerged as one of the significant vaccine manufacturing hubs. Indian manufacturers account for 60 per cent of vaccine supplies made to UNICEF.” It added that regardless of which nation comes up with the Covid vaccine, they will have to depend on India for its ability for mass production.

Beginning of end, India sounds confident of Covid vaccine
Six Indian companies are working on a vaccine for COVID-19. (Representative Image). Pixabay

Stressing the crucial role India plays in the vaccine, the government cited how two key players have inked contract with India. Both — AAZD1222 developed by Jenner Institute of University of Oxford and licensed to AstraZeneca; and The MRNA-1273 vaccine developed by Kaiser Permanente Washington Health Research Institute “inked an agreement with Indian manufacturers for production of the Covid vaccines”.

Also Read: Malaika Arora Shares Home Remedy to Boost Immunity

Talking about how Covaxin works, the ministry in a press statement explained, “The Bharat Biotech’s COVAXIN uses the virus isolated from an Indian patient by the National Institute of Virology to develop the inactivated virus vaccine.”

Earlier on July 2, the Indian Council of Medical Research (ICMR) head Dr Balram Bhargava wrote to 12 trial sites for the Covid-19 vaccine candidate, Covaxin, stating that all clinical trials need to be completed by August 15. (IANS)

STAY CONNECTED

19,120FansLike
362FollowersFollow
1,777FollowersFollow

Most Popular

Detection of Corona Virus In Nasal Swab Through Smartphone

A team of researchers in the US has developed an assay that can detect the presence of the Covid-19 virus in a nasal swab...

Autoimmune Disease Causes Early Death Risks During COVID

Researchers have now found that people with rare autoimmune rheumatic diseases are at a greater risk of dying at a younger age amid the...

Japanese Capsule To Bring Asteroid Sample To Earth

A Japanese capsule is on its way to bring a precious sample from asteroid Ryugu which is expected to help in a better understanding...

Unmet Job Expectations Cause Suicide Risks in Men

Declines in jobs may have left some working-class men frustrated by unmet job expectations and they are more likely to suffer an early death...

Sania Mirza Learnt To Appreciate Small Things in Pandemic

Indian tennis ace Sania Mirza says the Covid-19 pandemic has taught her to appreciate the small things, and value every moment spent with family. Sania...

Your Complete Guide On How To Select The Best Credit Card

The trend of using a credit card is on the rise for the affluent population, who can afford the expense. Given the abundant variety...

Women With PTSD And Depression Are On Higher Risk Of Early Death

Women with post-traumatic stress disorder (PTSD) and depression have an almost fourfold greater risk of early death from cardiovascular disease, respiratory disease, type 2...

World-Famous Hornbill Festival From Nagaland Goes Virtual

The Naga Heritage Village, the epicenter of the world-famous Hornbill Festival is quiet this year with the celebrations turned online due to the Covid-19...

Recent Comments